Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

C-Rad

31.55 SEK

-0.94 %

Less than 1K followers

CRAD B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-0.94 %
-1.25 %
+4.13 %
-9.86 %
+5.17 %
+4.30 %
-16.97 %
-19.10 %
+142.98 %

C-Rad operates in the medical technology industry and focuses on the development and manufacture of systems for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The business is present on a global level, with a main presence in Europe, North America and Asia. C-Rad was founded in 2004 and is headquartered in Uppsala, Sweden.

Read more
Market cap
1.07B SEK
Turnover
1.21M SEK
Revenue
469M
EBIT %
14.93 %
P/E
18.89
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12/2
2026

Annual report '25

6/5
2026

Interim report Q1'26

7/5
2026

General meeting '26

All
Research
Webcasts
Press releases
3rd party
ShowingAll content types
Regulatory press release12/8/2025, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 49, 2025

C-Rad
Regulatory press release12/1/2025, 12:02 PM

Finansinspektionen: Flaggningsmeddelande i C-Rad AB

C-Rad
Regulatory press release12/1/2025, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 48, 2025

C-Rad

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release11/27/2025, 10:15 AM

Finansinspektionen: Flaggningsmeddelande i C-Rad AB

C-Rad
Regulatory press release11/26/2025, 10:01 AM

Finansinspektionen: Flaggningsmeddelande i C-Rad AB

C-Rad
Regulatory press release11/25/2025, 10:14 AM

Finansinspektionen: Flaggningsmeddelande i C-Rad AB

C-Rad
Regulatory press release11/24/2025, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 47, 2025

C-Rad
Regulatory press release11/17/2025, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 46, 2025

C-Rad
Regulatory press release11/10/2025, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 45, 2025

C-Rad
C-RAD, Audiocast, Q3'25
Webcast10/23/2025, 9:00 AM

C-RAD, Audiocast, Q3'25

C-Rad
Regulatory press release10/22/2025, 3:55 PM

C-RAD har beslutat om återköp av egna B-aktier

C-Rad
Regulatory press release10/22/2025, 3:55 PM

C-RAD has decided to repurchase own class B shares

C-Rad
Regulatory press release10/21/2025, 5:00 PM

C-RAD AB:s Delårsrapport Q3 2025

C-Rad
Regulatory press release10/21/2025, 5:00 PM

C-RAD ABs Interim Report Q3 2025

C-Rad
Press release10/21/2025, 4:20 PM

C-RAD tidigarelägger godkännande av delårsrapport för kv 3 2025

C-Rad
Press release10/21/2025, 4:20 PM

C-RAD advances approval of interim report for Q3 2025

C-Rad
Regulatory press release10/21/2025, 4:15 PM

C-RADs VD lämnar, CFO Linda Frölén utses till tillförordnad VD, Johan Danielsson utses till vice VD

C-Rad
Regulatory press release10/21/2025, 4:15 PM

C-RAD's CEO leaves, CFO Linda Frölén appointed acting CEO, Johan Danielsson is appointed deputy CEO

C-Rad
Press release10/9/2025, 6:00 AM

Inbjudan till presentation av C-RADs delårsrapport samt rapport för tredje kvartalet 2025

C-Rad
Press release10/9/2025, 6:00 AM

Invitation to presentation of C-RAD’s interim report and report for the third quarter 2025

C-Rad
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.